KLISBio Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.65M

  • Investors
  • 9

KLISBio General Information

Description

Developer of an innovative medical technology designed to find new tissue regeneration methods. The company's technology offers silk-based bio-materials that help to regenerate human tissues, including those present in the vascular system and then to degrade and be safely absorbed in the body, enabling medical research companies to avail premium products harnessing the power of nano-fibers and use them for the treatment of tissue-related diseases.

Contact Information

Website
www.klis.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Corporate Office
  • Via Ludovico Ariosto, 21
  • Bresso
  • 20091 Bresso
  • Italy

KLISBio Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KLISBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 08-Nov-2023 $2.65M 000.00 Completed Generating Revenue
6. Later Stage VC 31-Dec-2022 00.000 000.00 000.00 Completed Generating Revenue
5. Early Stage VC (Series A) 21-Apr-2016 00.000 00.000 Completed Generating Revenue
4. Seed Round 11-Dec-2015 00000 00000 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Grant 05-Aug-2015 $55K Completed Generating Revenue
1. Grant 05-Dec-2014 $31.1K Completed Startup
To view KLISBio’s complete valuation and funding history, request access »

KLISBio Patents

KLISBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3227954-A1 Biomimetic peptides and their use in bone regeneration Pending 09-Aug-2021 000000000
EP-4384540-A1 Biomimetic peptides and their use in bone regeneration Pending 09-Aug-2021 000000000
AU-2018248085-A1 Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers Inactive 04-Apr-2017 000000000
EP-3607117-A1 Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers Pending 04-Apr-2017 000000000
US-20200109491-A1 Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers Inactive 04-Apr-2017 D01D5/003 0
To view KLISBio’s complete patent history, request access »

KLISBio Executive Team (6)

Name Title Board Seat
Rodrigo Bianchi President & Chairman
Antonio Alessandrino Ph.D Co-Founder, Chief Technology Officer & Board Member
Giuliano Freddi Ph.D Co-Founder & Chief Scientific Officer
Lorenzo Sala Co-Founder & Regulatory Specialist
Jason Schense Ph.D Chief Business Officer
You’re viewing 5 of 6 executive team members. Get the full list »

KLISBio Board Members (4)

Name Representing Role Since
Antonio Alessandrino Ph.D KLISBio Co-Founder, Chief Technology Officer & Board Member 000 0000
Gabriele Grecchi Self Co-Founder, Chief Executive Officer & Board Member 000 0000
Rodrigo Bianchi KLISBio President & Chairman 000 0000
You’re viewing 3 of 4 board members. Get the full list »

KLISBio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KLISBio Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Fund Venture Capital Minority 000 0000 000000 0
Anya Capital Venture Capital Minority 000 0000 000000 0
Umberto Veronesi Foundation Limited Partner Minority 000 0000 000000 0
Angels for Impact Angel Group Minority 000 0000 000000 0
Xyence Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

KLISBio FAQs

  • When was KLISBio founded?

    KLISBio was founded in 2014.

  • Who is the founder of KLISBio?

    Antonio Alessandrino Ph.D, Giuliano Freddi Ph.D, Lorenzo Sala, and Gabriele Grecchi are the founders of KLISBio.

  • Who is the CEO of KLISBio?

    Gabriele Grecchi is the CEO of KLISBio.

  • Where is KLISBio headquartered?

    KLISBio is headquartered in Bresso, Italy.

  • What is the size of KLISBio?

    KLISBio has 16 total employees.

  • What industry is KLISBio in?

    KLISBio’s primary industry is Therapeutic Devices.

  • Is KLISBio a private or public company?

    KLISBio is a Private company.

  • What is KLISBio’s current revenue?

    The current revenue for KLISBio is 00000.

  • How much funding has KLISBio raised over time?

    KLISBio has raised $11.6M.

  • Who are KLISBio’s investors?

    European Innovation Council Fund, Anya Capital, Umberto Veronesi Foundation, Angels for Impact, and Xyence are 5 of 9 investors who have invested in KLISBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »